Apellis Pharmaceuticals Inc
NASDAQ:APLS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Apellis Pharmaceuticals Inc
NASDAQ:APLS
|
US |
|
Fine Organic Industries Ltd
NSE:FINEORG
|
IN |
|
I
|
Intekplus Co Ltd
KOSDAQ:064290
|
KR |
|
V
|
Vonovia SE
LSE:0QFT
|
DE |
|
S
|
Skycity Entertainment Group Ltd
ASX:SKC
|
NZ |
|
F
|
Facilities By ADF PLC
F:ZC8
|
UK |
|
Xantippe Resources Ltd
ASX:XTC
|
AU |
|
Redhill Biopharma Ltd
NASDAQ:RDHL
|
IL |
|
E
|
Ellaktor SA
XBER:HLL
|
GR |
|
Capgemini SE
OTC:CGEMY
|
FR |
|
W
|
Wilson Bayly Holmes - Ovcon Ltd
JSE:WBO
|
ZA |
|
Mizuho Financial Group Inc
TSE:8411
|
JP |
|
C
|
Cheesecake Factory Inc
DUS:CF2
|
US |
|
Americas Gold and Silver Corporation
TSX:USA
|
CA |
Bankruptcy Probability
Apellis Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Apellis Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Apellis Pharmaceuticals Inc
NASDAQ:APLS
|
5.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
398.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
186.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
155.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
38.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Apellis Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Apellis Pharmaceuticals Inc has total debt of 362.2m USD. This includes both short-term (0 USD) and long-term (362.2m USD) debt.
You can find a full breakdown on its Balance Sheet.
